Hydreight Technologies Enters the At-Home STI Testing Market With Exclusive Distribution and 50,000 Pre-Orders

Executive Summary

• Hydreight Technologies entered an exclusive distribution agreement with Health Screen Collective (HSC) to sell HSC’s at‑home STI pre‑screening kits on Hydreight’s national digital health platform.
• The company has secured approximately 50,000 pre‑orders for the kits, with deliveries slated to begin in early 2026.
• The partnership expands Hydreight’s service offering into a high‑frequency, repeat‑use healthcare category and is expected to drive downstream clinical services, pharmacy fulfillment, and increased platform utilization.

Key Details

• Agreement Scope: Exclusive distributor of HSC’s at‑home STI pre‑screen testing kits across the United States via Hydreight’s platform.
• Pre‑Orders Secured: ~50,000 kits ordered by enterprise partners, healthcare operators, and distribution channels.
• Delivery Timeline: First shipments expected in early 2026.
• Test Panel Includes:
• Chlamydia trachomatis
• Neisseria gonorrhoeae
• Trichomonas vaginalis
• Mycoplasma genitalium
• Candida albicans
• Gardnerella vaginalis
• Technology: Lateral‑flow immunoassay providing rapid (minutes) results; validation data indicate high sensitivity, specificity, and overall accuracy comparable to laboratory‑based screening.
• Integrated Care Flow: Pre‑screen → licensed medical review → confirmatory testing → clinical consultation → treatment coordination within Hydreight’s platform.
• Strategic Rationale:
• STI screening is a high‑frequency, repeatable service driving recurring revenue.
• The partnership leverages Hydreight’s existing nurse/doctor/pharmacy network and digital infrastructure to capture new user engagement and downstream services.
• CEO Quote: “When you combine fast, at‑home screening with licensed providers and national fulfillment, you remove friction from a category that desperately needs it… That’s where real healthcare transformation happens.” – Shane Madden, CEO & Director.

Notable Quotes

“This category highlights exactly why our platform exists,” said Shane Madden, Chief Executive Officer of Hydreight. “When you combine fast, at‑home screening with licensed providers and national fulfillment, you remove friction from a category that desperately needs it. That’s where real healthcare transformation happens.”

Materiality Assessment: Material – Positive (the agreement introduces a new revenue stream, demonstrates strong market demand, and aligns with the company’s growth strategy).